Recursion Pharmaceuticals (RXRX) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.43
-0.38
-0.34
-0.29

Details

Expected EPS
-0.38
Actual EPS
-0.43
Surprise EPS
-0.05
Surprise Percent
+13.16%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.43 per share for Q3 2023.

0 Comments

Share your thoughts